CClinicalTrials.gg
RecruitingNCT06250699Updated Feb 13, 2024

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

An interventional study of Tubeless laparoscopic adrenalectomy and Drainage tube in Nonfunctional Adrenal Cortex Adenoma, Primary Aldosteronism and Cushing Syndrome, sponsored by Zhe Meng. Recruiting at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-02-13.

Sponsored by Zhe Meng · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are:

  1. The safety of tubeless laparoscopic adrenalectomy;
  2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.
Read the detailed description

The design type of this study is a prospective single center randomized controlled study, with a plan to recruit 200 patients who underwent laparoscopic adrenalectomy for the study. The intervention measures mainly include whether to indwelling drainage tubes. Prior to the start of the trial, our center had performed laparoscopic adrenalectomy on 89 patients without any obvious retroperitoneal fluid accumulation, redness, swelling, or fever, and the recovery was smooth. Step 1 of the research: Select patients who meet the criteria for laparoscopic adrenalectomy Step 2: Sign informed consent form Step 3: Randomly draw lots and divide them into two groups: no tube group (experimental group of 100 cases) and indwelling drainage tube group (control group of 100 cases) Step 4: Perform surgical plan according to grouping results Step 5: Test blood routine and ERAS related indicators 1-3 days after surgery Step 6: Follow up adrenal ultrasound at 1 month and 6 months after surgery Step 7: Follow up and analyze data Random plan Use block randomization method, using software SAS9.4 TS1M7, random seed number 2023092311 Observation items and testing time points 1. Test hemoglobin and drainage volume on 1-3 days after surgery Pain score, first time out of bed, intestinal ventilation time, adrenal ultrasound, postoperative fever, wound infection, and other indicators; During the follow-up one month after surgery, the adrenal region color ultrasound should also be tested; 3. During the follow-up examination at 6 months after surgery, ultrasound of the adrenal region should also be detected; Efficacy evaluation criteria and effectiveness evaluation methods: Whether the indwelling drainage tube has a promoting effect on the patient's rapid recovery (such as pain score, first time out of bed, intestinal ventilation time, etc.). Safety evaluation methods mainly include the subject's blood routine and vital signs.

02

Conditions studied

  • Nonfunctional Adrenal Cortex Adenoma
  • Primary Aldosteronism
  • Cushing Syndrome

Keywords

  • tubeless
  • laparoscopic adrenalectomy
  • rapid recovery
03

In context

Adenoma

657 studies on the registry are indexed under Adenoma; 98 are open to participants now.

This study's planned enrollment of 200 is below the median of 250 across 412 interventional studies indexed under Adenoma.

Browse Adenoma studies →

Lead sponsor

This is the only study on the registry with Zhe Meng as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications
  2. The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.

Exclusion criteria

Exclusion Criteria:

  1. Patients with complications that seriously affect treatment or quality of life
  2. The patient has any physical condition that the researcher believes will affect the clinical status
  3. Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year
  4. Pregnant or lactating patients
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    no tube

    no drainage tube after laparoscopic adrenalectomy

    Procedure: Tubeless laparoscopic adrenalectomy

  • Experimental
    Drainage tube

    tube drainage after laparoscopic adrenalectomy

    Procedure: Drainage tube

Interventions

  • ProcedureTubeless laparoscopic adrenalectomy

    No drainage tube placed after laparoscopic adrenalectomy

  • ProcedureDrainage tube

    Placing drainage tubes after laparoscopic adrenalectomy

06

What researchers measure

Primary outcomes

  1. Pain score

    Pain rating scale after laparoscopic adrenalectomy by VAS(visual analog scale for pain ) scale. The score ranges from 1 to 10, and the degree of pain gradually increases.

    Time frame: 1-3 days after surgery

  2. First time up and about

    First time up and about after laparoscopic adrenalectomy

    Time frame: 1-3 days after surgery

  3. Recovery time of intestinal function

    Recovery time of intestinal function after laparoscopic adrenalectomy

    Time frame: 1-3 days after surgery

  4. Hematoma

    Detection of obvious hematoma (Hematoma area\> 4cm x 4cm) in the surgical area through color ultrasound. The results are expressed as yes or no.

    Time frame: 1-3 days after surgery

Secondary outcomes

  1. fever

    Does the patient experience fever (The thermometer shows a temperature greater than 37.3 ° C) after laparoscopic adrenalectomy.

    Time frame: 1-3 days after surgery

07

Study locations

1 of 1 sites recruiting
  • Zhongnan hospital
    Wuhan, Hubei 430071, China
    Recruiting
08

References and documents

Publications

  • Chai S, Pan Q, Liang C, Zhang H, Xiao X, Li B. Should surgical drainage after lateral transperitoneal laparoscopic adrenalectomy be routine?-A retrospective comparative study. Gland Surg. 2021 Jun;10(6):1910-1919. doi: 10.21037/gs-20-829. PubMed 34268075 ↗
  • Lelli G, Micalizzi A, Iossa A, Fassari A, Concistre A, Circosta F, Petramala L, De Angelis F, Letizia C, Cavallaro G. Application of enhanced recovery after surgery (ERAS) protocols in adrenal surgery: A retrospective, preliminary analysis. J Minim Access Surg. 2024 Apr 1;20(2):163-168. doi: 10.4103/jmas.jmas_319_22. Epub 2023 May 10. PubMed 37282440 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06250699
Lead sponsor
Zhe Meng
Responsible party
Zhe Meng (Deputy chief physician, Zhongnan Hospital) — Sponsor-investigator
First posted
Feb 9, 2024
Start date
Jan 3, 2024
Primary completion
Dec 30, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Feb 13, 2024

Study contacts

meng zhe
Contact
mengzhe@whu.edu.cn
15387041020
meng zhe
principal investigator · Wuhan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion